These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20211664)

  • 21. Sorting out difficulties in immunological diagnosis of neurocysticercosis: Development and assessment of real time loop mediated isothermal amplification of cysticercal DNA in blood.
    Goyal G; Phukan AC; Hussain M; Lal V; Modi M; Goyal MK; Sehgal R
    J Neurol Sci; 2020 Jan; 408():116544. PubMed ID: 31759221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocysticercosis: Diagnostic problems & current therapeutic strategies.
    Rajshekhar V
    Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the performance of 5 commercialized enzyme immunoassays for the detection of Taenia solium antibodies and for the diagnosis of neurocysticercosis.
    Carod JF; Randrianarison M; Razafimahefa J; Ramahefarisoa RM; Rakotondrazaka M; Debruyne M; Dautigny M; Cazal P; Andriantseheno ML; Charles ER
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):85-9. PubMed ID: 22085773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.
    Prasad KN; Verma A; Srivastava S; Gupta RK; Pandey CM; Paliwal VK
    Trans R Soc Trop Med Hyg; 2011 Sep; 105(9):531-6. PubMed ID: 21764415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2D-PAGE analysis of Taenia solium metacestode 10-30 kDa antigens for the serodiagnosis of neurocysticercosis in children.
    Atluri VS; Singhi PD; Khandelwal N; Malla N
    Acta Trop; 2011 May; 118(2):165-9. PubMed ID: 21354092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis.
    Tuero I; Palma S; Cabeza F; Saleemi S; Rodriguez S; Gonzales I; Mayta H; Mahanty S; Garcia HH; Gilman RH;
    PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004143. PubMed ID: 26506532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.
    Alvarez JI; Mishra BB; Gundra UM; Mishra PK; Teale JM
    Parasitology; 2010 Mar; 137(3):359-72. PubMed ID: 20109250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis.
    Chung JY; Bahk YY; Huh S; Kang SY; Kong Y; Cho SY
    J Infect Dis; 1999 Oct; 180(4):1307-15. PubMed ID: 10479162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical signs for identification of neurocysticercosis in swine naturally infected with Taenia solium.
    Prasad KN; Chawla S; Prasad A; Tripathi M; Husain N; Gupta RK
    Parasitol Int; 2006 Jun; 55(2):151-4. PubMed ID: 16516537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis.
    Arruda GC; da Silva AD; Quagliato EM; Maretti MA; Rossi CL
    Trop Med Int Health; 2005 Oct; 10(10):1005-12. PubMed ID: 16185235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis.
    Verma A; Prasad KN; Nyati KK; Singh SK; Singh AK; Paliwal VK; Gupta RK
    Parasitology; 2011 Sep; 138(11):1423-8. PubMed ID: 21813044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe.
    Stelzle D; Abraham A; Kaminski M; Schmidt V; De Meijere R; Bustos JA; Garcia HH; Sahu PS; Bobić B; Cretu C; Chiodini P; Dermauw V; Devleesschauwer B; Dorny P; Fonseca A; Gabriël S; Morales MÁG; Laranjo-González M; Hoerauf A; Hunter E; Jambou R; Jurhar-Pavlova M; Reiter-Owona I; Sotiraki S; Trevisan C; Vilhena M; Walker NF; Zammarchi L; Winkler AS
    J Travel Med; 2023 Feb; 30(1):. PubMed ID: 36222148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review.
    Gripper LB; Welburn SC
    Infect Dis Poverty; 2017 Apr; 6(1):31. PubMed ID: 28376856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-generation sequencing of cerebrospinal fluid for the diagnosis of neurocysticercosis.
    Fei X; Li C; Zhang Y; Zhang H; Liu X; Ji X; Shi Y; Liu N; Wu M; Du F; Yang Y; Dai W; Liu T; He Y; Bian T; Zhou H; An X; Cai Z; Shi J; Feng G; Shi M; Zhao G
    Clin Neurol Neurosurg; 2020 Jun; 193():105752. PubMed ID: 32220712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of ICAM-1 among symptomatic neurocysticercosis.
    Prasad A; Prasad KN; Gupta RK; Pradhan S
    J Neuroimmunol; 2009 Jan; 206(1-2):118-20. PubMed ID: 18947884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Study of Paired Serum and Cerebrospinal Fluid Samples from Neurocysticercosis Patients for the Detection of Specific Antibody to Taenia solium Immunodiagnostic Antigen.
    Sako Y; Takayanagui OM; Odashima NS; Ito A
    Trop Med Health; 2015 Sep; 43(3):171-6. PubMed ID: 26543392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples.
    Manhani MN; Ribeiro VS; Cardoso R; Ueira-Vieira C; Goulart LR; Costa-Cruz JM
    Parasite Immunol; 2011 Jun; 33(6):322-9. PubMed ID: 21323932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.
    Esquivel-Velázquez M; Ostoa-Saloma P; Morales-Montor J; Hernández-Bello R; Larralde C
    J Biomed Biotechnol; 2011; 2011():516042. PubMed ID: 22131808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocysticercosis infection and disease-A review.
    Gripper LB; Welburn SC
    Acta Trop; 2017 Feb; 166():218-224. PubMed ID: 27880878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of specific cysticercus antigen in the urine for diagnosis of neurocysticercosis.
    Parija M; Biswas R; Harish BN; Parija SC
    Acta Trop; 2004; 92(3):253-60. PubMed ID: 15533295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.